BRANDY STEWART: Open Payments
NPI 1801017116 · KINGSTON SPRINGS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 45 payments from 17 companies in 2025. Trend: 2023 $1,468 · 2024 $865 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| Astellas Pharma US Inc | 4 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| ABBVIE INC. | 3 | $94 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Verona Pharma, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $42 |
Products named: Veozah, CAPLYTA, AIRSUPRA, GEMTESA, TRELEGY ELLIPTA, QULIPTA, JARDIANCE, REXULTI.
Industry payments across TN — which companies pay providers there.
